نتایج جستجو برای: leucovorin

تعداد نتایج: 2615  

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2014
K Gerasimova M Avxentyeva O Rebrova

In RCT both tegafur + calcium folinate and capecitabine had a statistically signi cant advantage over 5- uorouracil + calcium folinate: the full and partial objective tumor response was achieved in more patients (table 1). There was no statistically signi cant difference between oral tegafur, both in monotherapy or in combination with calcium folinate, and capecitabine for advanced CRC treat...

Journal: :The Ulster Medical Journal 1993
R. J. Cuthbert J. I. Craig C. A. Ludlam

In recent years methotrexate has been used increasingly in combination chemo-therapeutic regimens for the treatment of aggressive non-Hodgkin's lymphoma. I Its principal toxic effects are bone marrow suppression, gastrointestinal mucositis, hepatitis, renal impairment, and erythematous rashes. The Stevens-Johnson syndrome has been reported previously in two children receiving high-dose methotre...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007
Alfredo Falcone Sergio Ricci Isa Brunetti Elisabetta Pfanner Giacomo Allegrini Cecilia Barbara Lucio Crinò Giovanni Benedetti Walter Evangelista Laura Fanchini Enrico Cortesi Vincenzo Picone Stefano Vitello Silvana Chiara Cristina Granetto Gianfranco Porcile Luisa Fioretto Cinzia Orlandini Michele Andreuccetti Gianluca Masi

PURPOSE The Gruppo Oncologico Nord Ovest (GONO) conducted a phase III study comparing fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI [irinotecan 165 mg/m2 day 1, oxaliplatin 85 mg/m2 day 1, leucovorin 200 mg/m2 day 1, fluorouracil 3,200 mg/m2 48-hour continuous infusion starting on day 1, every 2 weeks]) with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI). MET...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Wandena S Siegel-Lakhai Jos H Beijnen Walter L Vervenne Henk Boot Marianne Keessen Melissa Versola Kevin M Koch Deborah A Smith Lini Pandite Dirk J Richel Jan H M Schellens

PURPOSE This phase I study was designed to determine the optimally tolerated regimen (OTR), safety, and clinical activity of lapatinib in combination with FOLFOX4 [oxaliplatin/leucovorin/5-fluorouracil (5-FU)] in patients with solid tumors. Furthermore, the pharmacokinetics of lapatinib, oxaliplatin, and 5-FU when given alone and in combination were evaluated. EXPERIMENTAL DESIGN This study w...

Journal: :Oncology reports 2009
Joo Young Jung Jung Hye Kwon Jung Han Kim Hun Ho Song Inho Kim Keun Seok Lee Hyo Jung Kim Dae Young Zang Jin Seok Ahn Jung-Ae Lee Young-Iee Park

Advanced or metastatic gastric cancer, which is one of the most common malignancies in Korea, is difficult to cure by surgery alone and generally requires combination chemotherapy. Paclitaxel is active against gastric cancer and when combined with 5-fluorouracil/leucovorin and/or cisplatin is effective in the treatment of gastric cancer. We attempted to determine the effect and safety with the ...

2016
Scott C. Howard John McCormick Ching-Hon Pui Randall K. Buddington R. Donald Harvey

: High-dose methotrexate (HDMTX), defined as a dose higher than 500 mg/m2, is used to treat a range of adult and childhood cancers. Although HDMTX is safely administered to most patients, it can cause significant toxicity, including acute kidney injury (AKI) in 2%-12% of patients. Nephrotoxicity results from crystallization of methotrexate in the renal tubular lumen, leading to tubular toxicity...

2011
Eun Kyoung Jeon Sook Hee Hong Tae Hee Kim Seung Eun Jung Ji Chan Park Hye-Sung Won Yoon-Ho Ko Sang Young Rho Young Seon Hong

PURPOSE The purpose of this study was to evaluate efficacy and toxicity of irinotecan, leucovorin and 5-fluorouracil (FOLFIRI) as second-line treatment after failure of oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) for advanced gastric cancer. MATERIALS AND METHODS Patients who received modified FOLFOX-4 as first-line treatment and then received sequential modified FOLFIRI for disease p...

Journal: :Cancer research and treatment : official journal of Korean Cancer Association 2006
Se Hoon Park Soo Yeon Jeon Kwang Il Ko Eunmi Nam Soo-Mee Bang Eun Kyung Cho Dong Bok Shin Jae Hoon Lee Woon Ki Lee Min Chung

PURPOSE Irinotecan, in combination with leucovorin/5-fluorouracil (FU) or with cisplatin, is known to be active for treating advanced gastric cancer (AGC). This pilot study evaluated a novel three-drug combination of irinotecan, leucovorin/FU and cisplatin as a first-line treatment of AGC. The primary endpoint was to assess the feasibility in anticipation of conducting a larger phase II study. ...

Journal: :The Journal of General Physiology 1953
Stanley D. Beck

1. The European corn borer larva has been shown to require a dietary source of one or more unidentified factors contained in corn leaves, grass juice concentrate, and certain other plant materials. The required factor or factors has been termed the corn leaf factor. 2. The corn leaf factor does not appear to be identical with any of the known B vitamins, or with ascorbic acid, sodium nucleate, ...

Journal: :Oncology 1999
C Bokemeyer J T Hartmann C Kollmannsberger F Mayer L Kanz

Since cancer is incurable in many patients, palliation of symptoms and quality-of-life issues are important aspects of therapy. Uracil and tegafur (UFT) plus calcium folinate are the components of the oral agent known as Orzel, which offers activity comparable to intravenously administered 5-fluorouracil (5-FU) combined with calcium folinate. Paclitaxel (Taxol), administered intravenously on a ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید